4 transcripts
PETS
Earnings call transcript
NASDAQ
2025 Q1
6 Aug 24
was primarily due to lower gross profit of $4.6 million, offset by a year-over-year decrease in stock compensation expense of $10 million related
PETS
Earnings call transcript
NASDAQ
2024 Q4
11 Jun 24
, representing growth of 6.6% year-over-year. The growth was due to incremental sales from the acquisition of PetCareRx, partially offset by a slowdown
PETS
Earnings call transcript
NASDAQ
2024 Q3
8 Feb 24
. The growth was due to incremental sales from the acquisition of PetCareRx partially offset by declines in PetMeds legacy new order and reorder sales
PETS
Earnings call transcript
NASDAQ
2024 Q1
31 Jul 23
to incremental sales from the combination of PetCareRx as well as growth in PetMed's new customer sales with a slight offset in PetMed's reorder sales
- Prev
- 1
- Next